🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06387485
Recruiting Not applicable

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

NCT06387485 · tracked via the Priya Life Science USA tracker
Sponsor
Ricoh USA, Inc.
Phase
Not applicable
Started
2024-03-01
Last updated
2026-02-06

Condition(s) studied

Sarcoma, EwingChondrosarcomaOsteosarcomaFibrous HistiocytomaFibrosarcoma

Investigational drug(s) / intervention(s)

3D Printed Anatomic ModelCT/MRI

3D Printed Anatomic Model: Patient-specific 3D printed anatomic model for pre-surgical planning

CT/MRI: Standard imaging type for bony tumors

Study summary

This prospective, multi-center, randomized controlled study aims to assess the efficacy of utilizing 3D printed models in preoperative planning for the excision of tumors involving bony structures within the body. The study is expected to last approximately 12 months and involve up to 150 subjects across up to 5 sites. Subjects will be randomized in a 1:1 ratio into either the experimental arm, utilizing 3D printed models and imaging, or the active comparator arm, using only imaging.

Primary endpoint: Operative time of surgical procedure.

Secondary endpoints: Reduction of blood loss, proportion of postoperative adverse events, and negative tumor margins.

Exploratory endpoints: Surgical planning ease, changes in surgical plan, and surgeon satisfaction.

Eligibility

Sex
ALL
Min age
13 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Subjects must be at least 13 years of age. 2. Subjects must have the ability to provide written informed consent. 3. Subjects must have tumor(s) invading bone and requiring surgical excision including but not limited to craniomaxillofacial, spine, long bone, and pelvis. 4. Subjects must be willing to have quality cross-sectional imaging that will allow for use to develop a 3D printed model. Exclusion Criteria: 1. Pregnant or nursing women. 2. Subjects that have a serious systemic pathology. 3. Subjects that have clotting disorders. 4. Subjects that have uncontrolled hypertension. 5. Subjects that are HIV-positive. 6. Subjects that are unable to be randomized; i.e surgical team prefers to use either 3D model or standard cross-sectional imaging for surgical pre-planning. 7. Subject anatomy has changed substantially since the date medical imaging from which the model is derived was obtained (as applicable). 8. Subject is a poor surgical or poor study candidate which may include, any medical, social or psychological problem that could complicate the procedure.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Kaiser Permanente Oakland Medical Center Oakland California Recruiting
William Beaumont University Hospital Royal Oak Michigan Recruiting
The Ohio State University Wexner Medical Center Columbus Ohio Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06387485 on ClinicalTrials.gov ↗ ← All trials in the USA